THEGROUP DC, LLC

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Biotechnology company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · $20,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Newborn screening for Metachromatic Leukodystrophy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem